Articles

'A very successful event for me, both the informal and formal networking is outstanding' Christine Lemke, VP Business Development, Medigene Industry Under Pressure According to the latest figures released by Datamonitor, drug development is growing more and more expensive, now estimated to be $800 million-$1 billion per product. Each day a launch is delayed can cost you up to $23 million in lost sales in the USA alone, and $37,000 per day in additional development costs. Given that the FDA approved just 17 new molecular entities and 2 biologic license applications in 2007, the lowest number recorded since 1983, you need to make sure you make the right choices in this difficult climate to ensure continued growth for your organisation.

Your Solution If you’re anything like our delegates, you find it’s getting more and more difficult to identify the events which will offer you real value and justify your time out of the office. Bio-partnering events should be about meeting the right people for your business and having the opportunity to assess potential and develop relationships. That’s why senior management goes back time and time again to BioBusiness, which offers the complete package to make sure you uncover these opportunities first: an optimal mix of formal and informal networking combined with industry strategy and competitive insight from industry leaders.

Networking Of course, when you attend an exclusive conference you want to be sure you really benefit from that high level of seniority, which is why BioBusiness has been carefully designed to offer you maximum formal and informal networking time. Use the improved partnering website to organise up to 14 formal one-to-ones each day and cement successful relationships during frequent coffee breaks, drinks receptions, roundtables and dinners. Your objective in attending any conference is to meet with potential partners, develop existing relationships and leave with a substantial number of leads to pursue further. Based on over 500 hundred hours of research with the industry, the BioBusiness agenda has been carefully refined to ensure you meet and exceed your networking goals.

One-to-ones. You will have access to the BioBusiness online partnering website up to 6 weeks before the event. This gives you time to pinpoint the delegates you want to meet and to plan out your schedule to ensure you plan up to 10 effective formal meetings per day. Breaks and lunches. With plenty of informal meeting space throughout the conference area, you can continue interesting discussions or grab 15 valuable minutes with your ideal partner. Dinner. This is where the BioBusiness exclusivity really comes into its own. No other conference of this type offers you the chance to network with so many high profile speakers and delegates at one dinner. Drinks. The perfect way to wind down after a long day and boost your informal networking. High Profile Agenda No other conference offers such an intimate and exclusive atmosphere in which to meet your peers and do effective business. Whatever your focus, information on your potential partners and competitors is invaluable. BioBusiness is the only conference to offer you 360° visibility on the industry you work in, with first hand deal insight from biotechs and pharma, overviews from regulatory bodies, coaching from independent experts and the hottest new innovation from across the globe. Who will you meet?

With so many senior decision makers at the conference, it’s inevitable that you’ll bump into people who can transform your business throughout the day, be it over coffee, in the conference room or relaxing over cocktails.

Think how useful it would be to grab a conversation with attendees such as:

• Onno van de Stople, CEO, Galapagos Pharma

• Denise Goode, Executive Director Strategic Transactions, AstraZeneca

• Shelagh Wilson, Head of CEED, GSK

• Yetunde Iowa, Director, BD, Eli Lilly

• Anthony Rosenberg, Global Head BD&L, Novartis

• Jeremy Levin, SVP Strategic Transactions, BMS

• Klaus Wilgenbus, SVP Licensing, Boehringer Ingelheim

• Ian Nicholson, CEO, Chroma Therapeutics

• Carlos de Sousa, VP Business Development, Nycomed

• Denise Pollard-Knight, Managing Director, Nomura

• John Goddard, SVP Strategic Planning and Business Development, AstraZeneca

• Barbara Yanni, VP and Chief Licensing Officer, Merck & Co

• Kees Been, CEO, Envivo Pharma

• Simon Moroney, CEO, Morphosys

• Gerd Zettlmeissl, CEO, Intercell

Of course, these attendees are not only going to be networking with you, they’ll also be sharing their recent deals, experiences and predictions for the future with you as well… What will you take away? Have you ever been asked to pay to speak at a conference? Chances are you have. And if you pay for participation, you pay for the right to pursue your own agenda while you’re presenting, right? That’s why BioBusiness speakers are chosen on their ability to present, their relevance to the industry at the current time and their willingness to share their experiences, not for their ability to pay.

What is means for you, as an attendee, is that you get much more honest case studies, much more controversial panels and much more insight into what makes your competitors tick at the moment:

• The Heads of BD&L Panel on 19th January is absolutely unmissable. With global heads from Boehringer Ingelheim, Novartis, Nycomed, Roche and AZ, you won’t get such a senior meeting of minds anywhere else.

• The Biotech CEO panel on 20th January gives you insight into the other end of the scale, with CEOs from top European and US biotechs comparing their expectations for 2010.

• Investment challenges on 19th and 20th January give you a chance to review how top biotechs are pitching big pharma, and to hear big pharma feedback and tips live on stage. If you’re not there learning from your competitors’ mistakes, someone else will be! What’s your focus?

With 2 dedicated focuses throughout the conference – on Biotech Funding on 19th January and Early-Stage Deals on 20th January, you can be sure to get the most out of the conference agenda. Whether you’re looking for funding, keen to stumble across a great pre-clinical product or just taking time out from meetings to catch up with industry developments, you can be sure to find the right topics and the right people to meet your needs.

How do you register? Prices for innovative biotech and pharma have been reduced this year by up to 20%, and frozen for other industry professionals, making it even easier to register your place in 2010. Call +44 (0) 207 368 9465 Email biobusiness@wbr.co.uk Visit www.biobusiness-conference.com

To make any comments on this article, or to ask a question of the author, please contact the publisher. If you would like to submit an article please subscribe to our Pharmalicensing Intelligence service.

The opinions expressed in the articles published in this section do not necessarily reflect those of Innovaro Pharmalicensing or Innovaro Corporation. No actions including proposals to or agreements with other companies should be taken by any reader without obtaining specific business or legal advice. Neither the publisher nor the authors accept any liability for any actions or activities undertaken by any reader or other third party as a consequence of these articles or for any errors or omissions therein.